ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions, is excited to announce additional product characterization for primary antibody targets on its ...

Characterizing the binding sites of monoclonal antibodies (mAbs) on target antigens, their epitopes, can aid in the discovery and development of new therapeutics, diagnostics, and vaccines. For ...

PHILADELPHIA, Feb. 13, 2020 /PRNewswire/ -- Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, announces the launch of ReadyMap ...

The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the primary target of many drug discovery efforts and is similarly utilized in each of the approved COVID-19 ...

Vaccines have arguably saved more lives than any other medical breakthrough. However, despite the long list of diseases that can now be controlled by vaccination, there are still some urgent unmet ...

Antibodies are a major component of adaptive immunity against invading pathogens. In this presentation, we will describe an analytical approach to characterize the antigen-specific antibody repertoire ...

New benchmark confirms LENS ai ’s ability to accurately predict binding on 17 previously unseen antibody-antigen complexes, achieving near-crystallography precision without prior training data. “It’s ...

In a recent article published in Scientific Reports, researchers performed immunoglobulin (Ig)M and IgG epitope mapping against 487 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...

The proteome is perhaps the most dynamic and valuable source of functional biological insight. Here, we introduce a novel single-molecule proteomic analysis approach that includes novel biochemistry ...